Agarwal Swati, Raman Rajiv, Kumari Rani Padmaja, Deshmukh Himanshu, Paul Pradeep G, Gnanamoorthy Perumal, Kumaramanickavel Govindasamy, Sharma Tarun
Shri Bhagvan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, India.
Ann Acad Med Singap. 2006 Aug;35(8):531-5.
The aim of this study was to compare the occurrence of diabetic retinopathy in targeted screening diabetic patients (Group I) with newly diagnosed diabetic patients in general practice (Group II).
This was an observational cross-sectional study. Data were obtained from 25,313 subjects who participated in the diabetic screening camps, and 128 newly diagnosed diabetes who presented to the diabetic retinopathy screening camps in general practice in rural and urban south India. The study variables were collected from all patients who underwent eye examination from the target screening detected diabetics [(n = 173) Group I] and those newly diagnosed in general practice [(n = 128) Group II]. The variations in prevalence of diabetic retinopathy and sight-threatening diabetic retinopathy in Group I and Group II and the factors affecting it were identified.
The occurrence of diabetic retinopathy was 6.35% (95% CI, 2.5-9.5) in Group I and 11.71% (95% CI, 5.6-16.4) in Group II. No significant difference was observed on occurrence of diabetic retinopathy, including sightthreatening retinopathy, in rural versus urban population and in Group I versus Group II. Patients diagnosed in general practice (Group II) with systolic blood pressure (BP) >140 were more likely to have retinopathy (P = 0.02).
Diabetic retinopathy including sightthreatening complications was found at the time of diagnosis of diabetes in the targeted screening group as well as in newly diagnosed diabetics in the general practice group.
本研究的目的是比较目标筛查糖尿病患者(第一组)与全科医疗中新诊断糖尿病患者(第二组)糖尿病视网膜病变的发生率。
这是一项观察性横断面研究。数据来自参加糖尿病筛查营的25313名受试者,以及印度南部城乡全科医疗中参加糖尿病视网膜病变筛查营的128名新诊断糖尿病患者。研究变量从所有接受眼部检查的患者中收集,这些患者包括目标筛查发现的糖尿病患者(第一组,n = 173)和全科医疗中新诊断的患者(第二组,n = 128)。确定了第一组和第二组中糖尿病视网膜病变和威胁视力的糖尿病视网膜病变患病率的差异及其影响因素。
第一组糖尿病视网膜病变的发生率为6.35%(95%CI,2.5 - 9.5),第二组为11.71%(95%CI,5.6 - 16.4)。在农村与城市人口以及第一组与第二组中,糖尿病视网膜病变(包括威胁视力的视网膜病变)的发生率未观察到显著差异。全科医疗中诊断出收缩压(BP)>140的患者(第二组)更有可能患有视网膜病变(P = 0.02)。
在目标筛查组的糖尿病诊断时以及全科医疗组的新诊断糖尿病患者中均发现了包括威胁视力并发症在内的糖尿病视网膜病变。